332 related articles for article (PubMed ID: 26279298)
1. Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival.
Fan L; Peng G; Sahgal N; Fazli L; Gleave M; Zhang Y; Hussain A; Qi J
Oncogene; 2016 May; 35(19):2441-52. PubMed ID: 26279298
[TBL] [Abstract][Full Text] [Related]
2. p300-Mediated Acetylation of Histone Demethylase JMJD1A Prevents Its Degradation by Ubiquitin Ligase STUB1 and Enhances Its Activity in Prostate Cancer.
Xu S; Fan L; Jeon HY; Zhang F; Cui X; Mickle MB; Peng G; Hussain A; Fazli L; Gleave ME; Dong X; Qi J
Cancer Res; 2020 Aug; 80(15):3074-3087. PubMed ID: 32522824
[TBL] [Abstract][Full Text] [Related]
3. Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells.
Fan L; Zhang F; Xu S; Cui X; Hussain A; Fazli L; Gleave M; Dong X; Qi J
Proc Natl Acad Sci U S A; 2018 May; 115(20):E4584-E4593. PubMed ID: 29712835
[TBL] [Abstract][Full Text] [Related]
4. Histone demethylase JMJD1A promotes expression of DNA repair factors and radio-resistance of prostate cancer cells.
Fan L; Xu S; Zhang F; Cui X; Fazli L; Gleave M; Clark DJ; Yang A; Hussain A; Rassool F; Qi J
Cell Death Dis; 2020 Apr; 11(4):214. PubMed ID: 32238799
[TBL] [Abstract][Full Text] [Related]
5. The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.
Wilson S; Fan L; Sahgal N; Qi J; Filipp FV
Oncotarget; 2017 May; 8(18):30328-30343. PubMed ID: 28416760
[TBL] [Abstract][Full Text] [Related]
6. Histone Demethylase JMJD1A Promotes Tumor Progression via Activating Snail in Prostate Cancer.
Tang DE; Dai Y; Xu SH
Mol Cancer Res; 2020 May; 18(5):698-708. PubMed ID: 32019811
[TBL] [Abstract][Full Text] [Related]
7. The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1.
Tee AE; Ling D; Nelson C; Atmadibrata B; Dinger ME; Xu N; Mizukami T; Liu PY; Liu B; Cheung B; Pasquier E; Haber M; Norris MD; Suzuki T; Marshall GM; Liu T
Oncotarget; 2014 Apr; 5(7):1793-804. PubMed ID: 24742640
[TBL] [Abstract][Full Text] [Related]
8. Targeting the KDM4B-AR-c-Myc axis promotes sensitivity to androgen receptor-targeted therapy in advanced prostate cancer.
Tang DE; Dai Y; He JX; Lin LW; Leng QX; Geng XY; Fu DX; Jiang HW; Xu SH
J Pathol; 2020 Oct; 252(2):101-113. PubMed ID: 32617978
[TBL] [Abstract][Full Text] [Related]
9. Jumonji domain-containing protein 1A promotes cell growth and progression via transactivation of c-Myc expression and predicts a poor prognosis in cervical cancer.
Liu J; Zhu M; Xia X; Huang Y; Zhang Q; Wang X
Oncotarget; 2016 Dec; 7(51):85151-85162. PubMed ID: 27835890
[TBL] [Abstract][Full Text] [Related]
10. Histone demethylase JMJD1A in cancer progression and therapeutic resistance.
Jeon HY; Ryu H; Pornour M; Qi J
Mol Carcinog; 2022 Apr; 61(4):392-396. PubMed ID: 35020958
[TBL] [Abstract][Full Text] [Related]
11. Histone demethylase JMJD1A promotes colorectal cancer growth and metastasis by enhancing Wnt/β-catenin signaling.
Peng K; Su G; Ji J; Yang X; Miao M; Mo P; Li M; Xu J; Li W; Yu C
J Biol Chem; 2018 Jul; 293(27):10606-10619. PubMed ID: 29802196
[TBL] [Abstract][Full Text] [Related]
12. R1 Regulates Prostate Tumor Growth and Progression By Transcriptional Suppression of the E3 Ligase HUWE1 to Stabilize c-Myc.
Lin TP; Li J; Li Q; Li X; Liu C; Zeng N; Huang JM; Chu GC; Lin CH; Zhau HE; Chung LWK; Wu BJ; Shih JC
Mol Cancer Res; 2018 Dec; 16(12):1940-1951. PubMed ID: 30042175
[TBL] [Abstract][Full Text] [Related]
13. Targeting USP1-dependent KDM4A protein stability as a potential prostate cancer therapy.
Cui SZ; Lei ZY; Guan TP; Fan LL; Li YQ; Geng XY; Fu DX; Jiang HW; Xu SH
Cancer Sci; 2020 May; 111(5):1567-1581. PubMed ID: 32133742
[TBL] [Abstract][Full Text] [Related]
14. Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation.
Xi Z; Yao M; Li Y; Xie C; Holst J; Liu T; Cai S; Lao Y; Tan H; Xu HX; Dong Q
Cell Death Dis; 2016 Jun; 7(6):e2252. PubMed ID: 27253416
[TBL] [Abstract][Full Text] [Related]
15. Histone demethylase Jumonji domain-containing 1A inhibits proliferation and progression of gastric cancer by upregulating runt-related transcription factor 3.
Ning K; Shao Y; He Y; Wang F; Cui X; Liu F; Li D; Li F
Cancer Sci; 2020 Oct; 111(10):3679-3692. PubMed ID: 32762126
[TBL] [Abstract][Full Text] [Related]
16. HUWE1 upregulation has tumor suppressive effect in human prostate cancer cell lines through c-Myc.
Qu H; Liu H; Jin Y; Cui Z; Han G
Biomed Pharmacother; 2018 Oct; 106():309-315. PubMed ID: 29966975
[TBL] [Abstract][Full Text] [Related]
17. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1.
Qiu MT; Fan Q; Zhu Z; Kwan SY; Chen L; Chen JH; Ying ZL; Zhou Y; Gu W; Wang LH; Cheng WW; Zeng J; Wan XP; Mok SC; Wong KK; Bao W
Oncotarget; 2015 Oct; 6(31):31702-20. PubMed ID: 26397136
[TBL] [Abstract][Full Text] [Related]
18. The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover.
Coffey K; Rogerson L; Ryan-Munden C; Alkharaif D; Stockley J; Heer R; Sahadevan K; O'Neill D; Jones D; Darby S; Staller P; Mantilla A; Gaughan L; Robson CN
Nucleic Acids Res; 2013 Apr; 41(8):4433-46. PubMed ID: 23435229
[TBL] [Abstract][Full Text] [Related]
19. Jmjd1a demethylase-regulated histone modification is essential for cAMP-response element modulator-regulated gene expression and spermatogenesis.
Liu Z; Zhou S; Liao L; Chen X; Meistrich M; Xu J
J Biol Chem; 2010 Jan; 285(4):2758-70. PubMed ID: 19910458
[TBL] [Abstract][Full Text] [Related]
20. c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer.
Maina PK; Shao P; Liu Q; Fazli L; Tyler S; Nasir M; Dong X; Qi HH
Oncotarget; 2016 Nov; 7(46):75585-75602. PubMed ID: 27689328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]